Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysis.
about
Cardiac risk in the treatment of breast cancer: assessment and management.Cancer drug related cardiotoxicity during breast cancer treatment.Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial.Current knowledge and future research directions in treatment-related second primary malignancies.Optimal systemic therapy for early breast cancer in women: a clinical practice guidelinePathologic complete response rates in triple-negative, HER2-positive, and hormone receptor-positive breast cancers after anthracycline-free neoadjuvant chemotherapy with carboplatin and paclitaxel with or without trastuzumab.Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.Cardiotoxicity of anthracycline therapy: current perspectivesHow do I follow patients with early breast cancer after completing adjuvant therapy.Short-term mortality in older patients treated with adjuvant chemotherapy for early-stage breast cancer.The role of palliative care in the last month of life in elderly cancer patients.Effects of high-intensity interval training on vascular function in breast cancer survivors undergoing anthracycline chemotherapy: design of a pilot studyAnti-cancer effects of Rhizoma Curcumae against doxorubicin-resistant breast cancer cells
P2860
Q28081385-3397FD7B-B807-4D87-9746-9351551D3C9AQ30251498-3E7EB476-DCFE-46D4-B380-F92CAED43C06Q33432594-322E9ADB-F6BD-4357-8393-2770CE143B3BQ34604460-B9FDB075-6900-4CE2-8205-6D9AF1AD2158Q35239634-9A9BFF0D-6972-40D3-A83C-E17D7D69C688Q36132952-997481F4-7DFA-493B-89D4-B6249A3FBD35Q36517999-C69B2F7F-EACA-4B2E-BD46-F180BAD70038Q36845348-E3D56E00-CDDA-4491-A2FD-7D03FE4B81EAQ38172001-83966B58-2F61-43ED-B3C5-78D8393DB9B1Q40768663-9D9967F8-CA09-4388-9AA2-DCDA716D96EAQ47644843-09DDCAEE-232F-4D30-B248-795966E8D2D1Q57110800-46B48B7C-5863-46EC-AFCB-1A371B742093Q57166874-61811DB2-0106-4102-AAA3-8F694C1951EF
P2860
Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mortality, leukemic risk, and ...... reast cancer: a meta-analysis.
@en
type
label
Mortality, leukemic risk, and ...... reast cancer: a meta-analysis.
@en
prefLabel
Mortality, leukemic risk, and ...... reast cancer: a meta-analysis.
@en
P2093
P2860
P1476
Mortality, leukemic risk, and ...... reast cancer: a meta-analysis.
@en
P2093
Fausto Petrelli
Karen Borgonovo
Mary Cabiddu
Sandro Barni
Veronica Lonati
P2860
P2888
P304
P356
10.1007/S10549-012-2121-6
P407
P577
2012-06-12T00:00:00Z
P6179
1039867169